Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
Anti-angiogenic agents are biological drugs used for treatment of retinal neovascular degenerative diseases.In this study, we aimed at in-silico analysis of interaction of vascular endothelial growth factor A (VEGFA), the main mediator of angiogenesis, with binding domains of anti-angiogenic agents used for treatment of retinal diseases, such as gi